APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Red Blood Cell Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Red Blood Cell Products Market Outlook and Growth Opportunities 2026

Report ID 174031970423 December 2025208 pages

Choose your research edition.

Industry ResearchRed Blood Cell Products Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Red Blood Cell Products Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Red Blood Cell Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Red Blood Cell Products Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Red Blood Cell Products Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Red Blood Cell Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Red Blood Cell Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Red Blood Cell Products market include China National Biotec Group, Weiguang Biological, Tiantan Biological, Shanghai RAAS Blood Products, Pilin Biological, Hualan Biological, Boyaa Bio-pharmaceutical, Bohui Innovation and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Red Blood Cell Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Red Blood Cell Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Red Blood Cell Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Red Blood Cell Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Red Blood Cell Products Segment by Company

China National Biotec Group

Weiguang Biological

Tiantan Biological

Shanghai RAAS Blood Products

Pilin Biological

Hualan Biological

Boyaa Bio-pharmaceutical

Bohui Innovation

Takeda Pharmaceutical

Sangamo Therapeutics

Octapharma

LFB Group

Kedrion

Kamada

Hemophilia Federation Europe

Grifols

Emergent BioSolutions

CSL Behring

Biotest

American Red Cross

Red Blood Cell Products Segment by Type

Washed Red Blood Cells

Concentrated Red Blood Cells

Frozen Red Blood Cells

Red Blood Cell Suspension

Irradiated Red Blood Cells

Others

Red Blood Cell Products Segment by Application

Blood Disease Supportive Treatment

Special Disease Management

Anemia Treatment

Acute Hemorrhage

Red Blood Cell Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Red Blood Cell Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Red Blood Cell Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Red Blood Cell Products significant trends, drivers, influence factors in global and regions.

6. To analyze Red Blood Cell Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Red Blood Cell Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Red Blood Cell Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Red Blood Cell Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Red Blood Cell Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Red Blood Cell Products industry.

Chapter 3: Detailed analysis of Red Blood Cell Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Red Blood Cell Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Red Blood Cell Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Red Blood Cell Products Industry Trends Table 2. Red Blood Cell Products Industry Drivers Table 3. Red Blood Cell Products Industry Opportunities and Challenges Table 4. Red Blood Cell Products Industry Restraints Table 5. Global Red Blood Cell Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Red Blood Cell Products Revenue Share by Company (2021-2026) Table 7. Global Red Blood Cell Products Sales Volume by Company (units) & (2021-2026) Table 8. Global Red Blood Cell Products Sales Volume Share by Company (2021-2026) Table 9. Global Red Blood Cell Products Average Price (USD/unit) of Company (2021-2026) Table 10. Global Red Blood Cell Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Red Blood Cell Products Key Company Manufacturing Base & Headquarters Table 12. Global Red Blood Cell Products Company, Product Type & Application Table 13. Global Red Blood Cell Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Red Blood Cell Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Washed Red Blood Cells Table 18. Significant Companies of Concentrated Red Blood Cells Table 19. Significant Companies of Frozen Red Blood Cells Table 20. Significant Companies of Red Blood Cell Suspension Table 21. Significant Companies of Irradiated Red Blood Cells Table 22. Significant Companies of Others Table 23. Global Red Blood Cell Products Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 24. Global Red Blood Cell Products Sales Volume by Type (2021-2026) & (units) Table 25. Global Red Blood Cell Products Sales Volume by Type (2027-2032) & (units) Table 26. Global Red Blood Cell Products Sales Volume Share by Type (2021-2026) Table 27. Global Red Blood Cell Products Sales Volume Share by Type (2027-2032) Table 28. Global Red Blood Cell Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Red Blood Cell Products Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Red Blood Cell Products Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Red Blood Cell Products Sales Value Share by Type (2021-2026) Table 32. Global Red Blood Cell Products Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Blood Disease Supportive Treatment Table 34. Significant Companies of Special Disease Management Table 35. Significant Companies of Anemia Treatment Table 36. Significant Companies of Acute Hemorrhage Table 37. Global Red Blood Cell Products Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 38. Global Red Blood Cell Products Sales Volume by Application (2021-2026) & (units) Table 39. Global Red Blood Cell Products Sales Volume by Application (2027-2032) & (units) Table 40. Global Red Blood Cell Products Sales Volume Share by Application (2021-2026) Table 41. Global Red Blood Cell Products Sales Volume Share by Application (2027-2032) Table 42. Global Red Blood Cell Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Red Blood Cell Products Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Red Blood Cell Products Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Red Blood Cell Products Sales Value Share by Application (2021-2026) Table 46. Global Red Blood Cell Products Sales Value Share by Application (2027-2032) Table 47. Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032 (units) Table 48. Global Red Blood Cell Products Sales by Region (2021-2026) & (units) Table 49. Global Red Blood Cell Products Sales Market Share by Region (2021-2026) Table 50. Global Red Blood Cell Products Sales by Region (2027-2032) & (units) Table 51. Global Red Blood Cell Products Sales Market Share by Region (2027-2032) Table 52. Global Red Blood Cell Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Red Blood Cell Products Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Red Blood Cell Products Sales Value Share by Region (2021-2026) Table 55. Global Red Blood Cell Products Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Red Blood Cell Products Sales Value Share by Region (2027-2032) Table 57. Global Red Blood Cell Products Market Average Price (USD/unit) by Region (2021-2026) Table 58. Global Red Blood Cell Products Market Average Price (USD/unit) by Region (2027-2032) Table 59. Global Red Blood Cell Products Sales by Country: 2021 VS 2025 VS 2032 (units) Table 60. Global Red Blood Cell Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 62. Global Red Blood Cell Products Sales Market Share by Country (2021-2026) Table 63. Global Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 64. Global Red Blood Cell Products Sales Market Share by Country (2027-2032) Table 65. Global Red Blood Cell Products Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Red Blood Cell Products Sales Value Market Share by Country (2021-2026) Table 67. Global Red Blood Cell Products Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Red Blood Cell Products Sales Value Market Share by Country (2027-2032) Table 69. China National Biotec Group Company Information Table 70. China National Biotec Group Business Overview Table 71. China National Biotec Group Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. China National Biotec Group Red Blood Cell Products Product Portfolio Table 73. China National Biotec Group Recent Development Table 74. Weiguang Biological Company Information Table 75. Weiguang Biological Business Overview Table 76. Weiguang Biological Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Weiguang Biological Red Blood Cell Products Product Portfolio Table 78. Weiguang Biological Recent Development Table 79. Tiantan Biological Company Information Table 80. Tiantan Biological Business Overview Table 81. Tiantan Biological Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Tiantan Biological Red Blood Cell Products Product Portfolio Table 83. Tiantan Biological Recent Development Table 84. Shanghai RAAS Blood Products Company Information Table 85. Shanghai RAAS Blood Products Business Overview Table 86. Shanghai RAAS Blood Products Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio Table 88. Shanghai RAAS Blood Products Recent Development Table 89. Pilin Biological Company Information Table 90. Pilin Biological Business Overview Table 91. Pilin Biological Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Pilin Biological Red Blood Cell Products Product Portfolio Table 93. Pilin Biological Recent Development Table 94. Hualan Biological Company Information Table 95. Hualan Biological Business Overview Table 96. Hualan Biological Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Hualan Biological Red Blood Cell Products Product Portfolio Table 98. Hualan Biological Recent Development Table 99. Boyaa Bio-pharmaceutical Company Information Table 100. Boyaa Bio-pharmaceutical Business Overview Table 101. Boyaa Bio-pharmaceutical Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio Table 103. Boyaa Bio-pharmaceutical Recent Development Table 104. Bohui Innovation Company Information Table 105. Bohui Innovation Business Overview Table 106. Bohui Innovation Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Bohui Innovation Red Blood Cell Products Product Portfolio Table 108. Bohui Innovation Recent Development Table 109. Takeda Pharmaceutical Company Information Table 110. Takeda Pharmaceutical Business Overview Table 111. Takeda Pharmaceutical Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Takeda Pharmaceutical Red Blood Cell Products Product Portfolio Table 113. Takeda Pharmaceutical Recent Development Table 114. Sangamo Therapeutics Company Information Table 115. Sangamo Therapeutics Business Overview Table 116. Sangamo Therapeutics Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Sangamo Therapeutics Red Blood Cell Products Product Portfolio Table 118. Sangamo Therapeutics Recent Development Table 119. Octapharma Company Information Table 120. Octapharma Business Overview Table 121. Octapharma Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Octapharma Red Blood Cell Products Product Portfolio Table 123. Octapharma Recent Development Table 124. LFB Group Company Information Table 125. LFB Group Business Overview Table 126. LFB Group Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. LFB Group Red Blood Cell Products Product Portfolio Table 128. LFB Group Recent Development Table 129. Kedrion Company Information Table 130. Kedrion Business Overview Table 131. Kedrion Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Kedrion Red Blood Cell Products Product Portfolio Table 133. Kedrion Recent Development Table 134. Kamada Company Information Table 135. Kamada Business Overview Table 136. Kamada Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Kamada Red Blood Cell Products Product Portfolio Table 138. Kamada Recent Development Table 139. Hemophilia Federation Europe Company Information Table 140. Hemophilia Federation Europe Business Overview Table 141. Hemophilia Federation Europe Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Hemophilia Federation Europe Red Blood Cell Products Product Portfolio Table 143. Hemophilia Federation Europe Recent Development Table 144. Grifols Company Information Table 145. Grifols Business Overview Table 146. Grifols Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Grifols Red Blood Cell Products Product Portfolio Table 148. Grifols Recent Development Table 149. Emergent BioSolutions Company Information Table 150. Emergent BioSolutions Business Overview Table 151. Emergent BioSolutions Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Emergent BioSolutions Red Blood Cell Products Product Portfolio Table 153. Emergent BioSolutions Recent Development Table 154. CSL Behring Company Information Table 155. CSL Behring Business Overview Table 156. CSL Behring Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. CSL Behring Red Blood Cell Products Product Portfolio Table 158. CSL Behring Recent Development Table 159. Biotest Company Information Table 160. Biotest Business Overview Table 161. Biotest Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Biotest Red Blood Cell Products Product Portfolio Table 163. Biotest Recent Development Table 164. American Red Cross Company Information Table 165. American Red Cross Business Overview Table 166. American Red Cross Red Blood Cell Products Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. American Red Cross Red Blood Cell Products Product Portfolio Table 168. American Red Cross Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Red Blood Cell Products Distributors List Table 172. Red Blood Cell Products Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Red Blood Cell Products Product Image Figure 2. Global Red Blood Cell Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Red Blood Cell Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Red Blood Cell Products Sales (2021-2032) & (units) Figure 5. Global Red Blood Cell Products Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Red Blood Cell Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Washed Red Blood Cells Image Figure 10. Concentrated Red Blood Cells Image Figure 11. Frozen Red Blood Cells Image Figure 12. Red Blood Cell Suspension Image Figure 13. Irradiated Red Blood Cells Image Figure 14. Others Image Figure 15. Global Red Blood Cell Products Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 16. Global Red Blood Cell Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Red Blood Cell Products Sales Volume Share by Type (2021-2032) Figure 18. Global Red Blood Cell Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Red Blood Cell Products Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Red Blood Cell Products Sales Value Share by Type (2021-2032) Figure 21. Blood Disease Supportive Treatment Image Figure 22. Special Disease Management Image Figure 23. Anemia Treatment Image Figure 24. Acute Hemorrhage Image Figure 25. Global Red Blood Cell Products Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 26. Global Red Blood Cell Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Red Blood Cell Products Sales Volume Share by Application (2021-2032) Figure 28. Global Red Blood Cell Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Red Blood Cell Products Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Red Blood Cell Products Sales Value Share by Application (2021-2032) Figure 31. Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 32. Global Red Blood Cell Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Red Blood Cell Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Red Blood Cell Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Red Blood Cell Products Sales Value (2021-2032) & (US$ Million) Figure 36. North America Red Blood Cell Products Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Red Blood Cell Products Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Red Blood Cell Products Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Red Blood Cell Products Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Red Blood Cell Products Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Red Blood Cell Products Sales Value (2021-2032) & (US$ Million) Figure 42. South America Red Blood Cell Products Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Red Blood Cell Products Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Red Blood Cell Products Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Red Blood Cell Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Red Blood Cell Products Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Red Blood Cell Products Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Washed Red Blood Cells
  • Concentrated Red Blood Cells
  • Frozen Red Blood Cells
  • Red Blood Cell Suspension
  • Irradiated Red Blood Cells
  • Others
Applications
  • Blood Disease Supportive Treatment
  • Special Disease Management
  • Anemia Treatment
  • Acute Hemorrhage
Companies covered
  • China National Biotec Group
  • Weiguang Biological
  • Tiantan Biological
  • Shanghai RAAS Blood Products
  • Pilin Biological
  • Hualan Biological
  • Boyaa Bio-pharmaceutical
  • Bohui Innovation
  • Takeda Pharmaceutical
  • Sangamo Therapeutics
  • Octapharma
  • LFB Group
  • Kedrion
  • Kamada
  • Hemophilia Federation Europe
  • Grifols
  • Emergent BioSolutions
  • CSL Behring
  • Biotest
  • American Red Cross

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Red Blood Cell Products Sales Value (2021-2032)
  4. 1.2.2 Global Red Blood Cell Products Sales Volume (2021-2032)
  5. 1.2.3 Global Red Blood Cell Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Red Blood Cell Products Market Dynamics
  1. 2.1 Red Blood Cell Products Industry Trends
  2. 2.2 Red Blood Cell Products Industry Drivers
  3. 2.3 Red Blood Cell Products Industry Opportunities and Challenges
  4. 2.4 Red Blood Cell Products Industry Restraints
3 Red Blood Cell Products Market by Company
  1. 3.1 Global Red Blood Cell Products Company Revenue Ranking in 2025
  2. 3.2 Global Red Blood Cell Products Revenue by Company (2021-2026)
  3. 3.3 Global Red Blood Cell Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Red Blood Cell Products Average Price by Company (2021-2026)
  5. 3.5 Global Red Blood Cell Products Company Ranking (2024-2026)
  6. 3.6 Global Red Blood Cell Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Red Blood Cell Products Company Product Type and Application
  8. 3.8 Global Red Blood Cell Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Red Blood Cell Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Red Blood Cell Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Red Blood Cell Products Market by Type
  1. 4.1 Red Blood Cell Products Type Introduction
  2. 4.1.1 Washed Red Blood Cells
  3. 4.1.2 Concentrated Red Blood Cells
  4. 4.1.3 Frozen Red Blood Cells
  5. 4.1.4 Red Blood Cell Suspension
  6. 4.1.5 Irradiated Red Blood Cells
  7. 4.1.6 Others
  8. 4.2 Global Red Blood Cell Products Sales Volume by Type
  9. 4.2.1 Global Red Blood Cell Products Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Red Blood Cell Products Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Red Blood Cell Products Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Red Blood Cell Products Sales Value by Type
  13. 4.3.1 Global Red Blood Cell Products Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Red Blood Cell Products Sales Value by Type (2021-2032)
  15. 4.3.3 Global Red Blood Cell Products Sales Value Share by Type (2021-2032)
5 Red Blood Cell Products Market by Application
  1. 5.1 Red Blood Cell Products Application Introduction
  2. 5.1.1 Blood Disease Supportive Treatment
  3. 5.1.2 Special Disease Management
  4. 5.1.3 Anemia Treatment
  5. 5.1.4 Acute Hemorrhage
  6. 5.2 Global Red Blood Cell Products Sales Volume by Application
  7. 5.2.1 Global Red Blood Cell Products Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Red Blood Cell Products Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Red Blood Cell Products Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Red Blood Cell Products Sales Value by Application
  11. 5.3.1 Global Red Blood Cell Products Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Red Blood Cell Products Sales Value by Application (2021-2032)
  13. 5.3.3 Global Red Blood Cell Products Sales Value Share by Application (2021-2032)
6 Red Blood Cell Products Regional Sales and Value Analysis
  1. 6.1 Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Red Blood Cell Products Sales by Region (2021-2032)
  3. 6.2.1 Global Red Blood Cell Products Sales by Region: 2021-2026
  4. 6.2.2 Global Red Blood Cell Products Sales by Region (2027-2032)
  5. 6.3 Global Red Blood Cell Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Red Blood Cell Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Red Blood Cell Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Red Blood Cell Products Sales Value by Region (2027-2032)
  9. 6.5 Global Red Blood Cell Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Red Blood Cell Products Sales Value (2021-2032)
  12. 6.6.2 North America Red Blood Cell Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Red Blood Cell Products Sales Value (2021-2032)
  15. 6.7.2 Europe Red Blood Cell Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Red Blood Cell Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Red Blood Cell Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Red Blood Cell Products Sales Value (2021-2032)
  21. 6.9.2 South America Red Blood Cell Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Red Blood Cell Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Red Blood Cell Products Sales Value Share by Country, 2025 VS 2032
7 Red Blood Cell Products Country-level Sales and Value Analysis
  1. 7.1 Global Red Blood Cell Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Red Blood Cell Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Red Blood Cell Products Sales by Country (2021-2032)
  4. 7.3.1 Global Red Blood Cell Products Sales by Country (2021-2026)
  5. 7.3.2 Global Red Blood Cell Products Sales by Country (2027-2032)
  6. 7.4 Global Red Blood Cell Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Red Blood Cell Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Red Blood Cell Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Red Blood Cell Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Red Blood Cell Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Red Blood Cell Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China National Biotec Group
  2. 8.1.1 China National Biotec Group Company Information
  3. 8.1.2 China National Biotec Group Business Overview
  4. 8.1.3 China National Biotec Group Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 China National Biotec Group Red Blood Cell Products Product Portfolio
  6. 8.1.5 China National Biotec Group Recent Developments
  7. 8.2 Weiguang Biological
  8. 8.2.1 Weiguang Biological Company Information
  9. 8.2.2 Weiguang Biological Business Overview
  10. 8.2.3 Weiguang Biological Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Weiguang Biological Red Blood Cell Products Product Portfolio
  12. 8.2.5 Weiguang Biological Recent Developments
  13. 8.3 Tiantan Biological
  14. 8.3.1 Tiantan Biological Company Information
  15. 8.3.2 Tiantan Biological Business Overview
  16. 8.3.3 Tiantan Biological Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tiantan Biological Red Blood Cell Products Product Portfolio
  18. 8.3.5 Tiantan Biological Recent Developments
  19. 8.4 Shanghai RAAS Blood Products
  20. 8.4.1 Shanghai RAAS Blood Products Company Information
  21. 8.4.2 Shanghai RAAS Blood Products Business Overview
  22. 8.4.3 Shanghai RAAS Blood Products Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio
  24. 8.4.5 Shanghai RAAS Blood Products Recent Developments
  25. 8.5 Pilin Biological
  26. 8.5.1 Pilin Biological Company Information
  27. 8.5.2 Pilin Biological Business Overview
  28. 8.5.3 Pilin Biological Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pilin Biological Red Blood Cell Products Product Portfolio
  30. 8.5.5 Pilin Biological Recent Developments
  31. 8.6 Hualan Biological
  32. 8.6.1 Hualan Biological Company Information
  33. 8.6.2 Hualan Biological Business Overview
  34. 8.6.3 Hualan Biological Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Biological Red Blood Cell Products Product Portfolio
  36. 8.6.5 Hualan Biological Recent Developments
  37. 8.7 Boyaa Bio-pharmaceutical
  38. 8.7.1 Boyaa Bio-pharmaceutical Company Information
  39. 8.7.2 Boyaa Bio-pharmaceutical Business Overview
  40. 8.7.3 Boyaa Bio-pharmaceutical Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio
  42. 8.7.5 Boyaa Bio-pharmaceutical Recent Developments
  43. 8.8 Bohui Innovation
  44. 8.8.1 Bohui Innovation Company Information
  45. 8.8.2 Bohui Innovation Business Overview
  46. 8.8.3 Bohui Innovation Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bohui Innovation Red Blood Cell Products Product Portfolio
  48. 8.8.5 Bohui Innovation Recent Developments
  49. 8.9 Takeda Pharmaceutical
  50. 8.9.1 Takeda Pharmaceutical Company Information
  51. 8.9.2 Takeda Pharmaceutical Business Overview
  52. 8.9.3 Takeda Pharmaceutical Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Pharmaceutical Red Blood Cell Products Product Portfolio
  54. 8.9.5 Takeda Pharmaceutical Recent Developments
  55. 8.10 Sangamo Therapeutics
  56. 8.10.1 Sangamo Therapeutics Company Information
  57. 8.10.2 Sangamo Therapeutics Business Overview
  58. 8.10.3 Sangamo Therapeutics Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sangamo Therapeutics Red Blood Cell Products Product Portfolio
  60. 8.10.5 Sangamo Therapeutics Recent Developments
  61. 8.11 Octapharma
  62. 8.11.1 Octapharma Company Information
  63. 8.11.2 Octapharma Business Overview
  64. 8.11.3 Octapharma Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Octapharma Red Blood Cell Products Product Portfolio
  66. 8.11.5 Octapharma Recent Developments
  67. 8.12 LFB Group
  68. 8.12.1 LFB Group Company Information
  69. 8.12.2 LFB Group Business Overview
  70. 8.12.3 LFB Group Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 LFB Group Red Blood Cell Products Product Portfolio
  72. 8.12.5 LFB Group Recent Developments
  73. 8.13 Kedrion
  74. 8.13.1 Kedrion Company Information
  75. 8.13.2 Kedrion Business Overview
  76. 8.13.3 Kedrion Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Kedrion Red Blood Cell Products Product Portfolio
  78. 8.13.5 Kedrion Recent Developments
  79. 8.14 Kamada
  80. 8.14.1 Kamada Company Information
  81. 8.14.2 Kamada Business Overview
  82. 8.14.3 Kamada Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Kamada Red Blood Cell Products Product Portfolio
  84. 8.14.5 Kamada Recent Developments
  85. 8.15 Hemophilia Federation Europe
  86. 8.15.1 Hemophilia Federation Europe Company Information
  87. 8.15.2 Hemophilia Federation Europe Business Overview
  88. 8.15.3 Hemophilia Federation Europe Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hemophilia Federation Europe Red Blood Cell Products Product Portfolio
  90. 8.15.5 Hemophilia Federation Europe Recent Developments
  91. 8.16 Grifols
  92. 8.16.1 Grifols Company Information
  93. 8.16.2 Grifols Business Overview
  94. 8.16.3 Grifols Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Grifols Red Blood Cell Products Product Portfolio
  96. 8.16.5 Grifols Recent Developments
  97. 8.17 Emergent BioSolutions
  98. 8.17.1 Emergent BioSolutions Company Information
  99. 8.17.2 Emergent BioSolutions Business Overview
  100. 8.17.3 Emergent BioSolutions Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Emergent BioSolutions Red Blood Cell Products Product Portfolio
  102. 8.17.5 Emergent BioSolutions Recent Developments
  103. 8.18 CSL Behring
  104. 8.18.1 CSL Behring Company Information
  105. 8.18.2 CSL Behring Business Overview
  106. 8.18.3 CSL Behring Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 CSL Behring Red Blood Cell Products Product Portfolio
  108. 8.18.5 CSL Behring Recent Developments
  109. 8.19 Biotest
  110. 8.19.1 Biotest Company Information
  111. 8.19.2 Biotest Business Overview
  112. 8.19.3 Biotest Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Biotest Red Blood Cell Products Product Portfolio
  114. 8.19.5 Biotest Recent Developments
  115. 8.20 American Red Cross
  116. 8.20.1 American Red Cross Company Information
  117. 8.20.2 American Red Cross Business Overview
  118. 8.20.3 American Red Cross Red Blood Cell Products Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 American Red Cross Red Blood Cell Products Product Portfolio
  120. 8.20.5 American Red Cross Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Red Blood Cell Products Value Chain Analysis
  2. 9.1.1 Red Blood Cell Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Red Blood Cell Products Sales Mode & Process
  6. 9.2 Red Blood Cell Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Red Blood Cell Products Distributors
  9. 9.2.3 Red Blood Cell Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst